Fresenius Medical Care NNN
lease analysis.
Fresenius Medical Care is one of the two largest dialysis providers in the United States (along with DaVita). Dialysis facilities are medical-use tenants with long-term lease commitments, stable Medicare reimbursement as the dominant revenue source, and difficulty relocating (dialysis centers require specific medical-use zoning and substantial tenant improvements). These factors create durable landlord economics.
Quick reference · Fresenius Medical Care
- Legal entity
- Fresenius Medical Care Holdings, Inc. (or subsidiary)
- Parent
- Fresenius Medical Care AG & Co. KGaA (FMS)
- Credit profile
- Investment-grade. Parent is a German healthcare conglomerate.
- Typical lease
- NNN with corporate guarantee.
- Typical term
- 10–15 years initial with 5-year options.
- Rent bumps
- 2–3% annual or 10% every 5 years.
- Prototype size
- ~6,000–10,000 SF in retail or medical plaza settings.
- Cap rate band
- 6.00–7.25% (2026)
About Fresenius Medical Care as a NNN tenant
Fresenius Medical Care is one of the two largest dialysis providers in the United States (along with DaVita). Dialysis facilities are medical-use tenants with long-term lease commitments, stable Medicare reimbursement as the dominant revenue source, and difficulty relocating (dialysis centers require specific medical-use zoning and substantial tenant improvements). These factors create durable landlord economics.
How Fresenius Medical Care structures its NNN leases
Fresenius NNN leases are triple net with corporate guarantee from the operating subsidiary and parent-level backing. Rent escalations are typically modest annual increases or periodic bumps.
Store specs and site profile
Dialysis centers are typically 6,000–10,000 SF with specialized medical build-out (dialysis stations, water treatment, specialized ventilation). Often located in medical plazas or retail-to-medical conversions.
Red flags on a Fresenius Medical Care NNN deal
- Medicare reimbursement policy changes affecting dialysis economics
- Short remaining primary term
- Competing dialysis center (DaVita) within 1 mile (less common but matters in smaller markets)
- Specialized tenant improvements that limit backfill universe if tenant vacates
What to underwrite before buying a Fresenius Medical Care property
- Remaining primary term and options
- Guarantor specifics and parent-level support
- Trade-area demographics (aging population density is a key driver)
- Backfill tenant universe given medical-specific improvements
- Competing dialysis presence
Frequently asked questions
Are dialysis centers good NNN investments?
Dialysis NNN with Fresenius or DaVita corporate guarantees, long primary terms, and strong demographic fundamentals are considered solid medical-NNN investments. Demand drivers (aging population, diabetes prevalence) are durable. Primary risks are Medicare reimbursement policy changes and site-specific backfill challenges.
How does Fresenius compare to DaVita as a NNN tenant?
Both are large-scale investment-grade dialysis operators. Fresenius parent is a major German healthcare company; DaVita is a U.S.-based public company. Cap rates are generally similar for comparable properties. Each lease should be underwritten on its specific terms.
Using Fresenius Medical Care in a 1031 exchange
Get the full 1031 Playbook.
Subscribe to The Upleg and we'll email the link — timelines, QI checklist, state clawback rules, and tenant-specific replacement strategies. Free.